Orchestra BioMed Holdings (OBIO) Enterprise Value Growth (1y) (2021 - 2026)
Orchestra BioMed Holdings (OBIO) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.65% |
| Dec 31, 2025 | -44.67% |
| Sep 30, 2025 | 0.06% |
| Jun 30, 2025 | 37.10% |
| Mar 31, 2025 | -113.66% |
| Dec 31, 2024 | -15.79% |
| Sep 30, 2024 | 11.63% |
| Jun 30, 2024 | 75.01% |
| Mar 31, 2024 | 81.64% |
| Dec 31, 2023 | -340.50% |
| Sep 30, 2023 | -14,655.92% |
| Jun 30, 2023 | -16,418.84% |
| Mar 31, 2023 | -8,860.10% |
| Dec 31, 2022 | -1,032.54% |
| Sep 30, 2022 | 58.77% |
| Jun 30, 2022 | 31.63% |
| Mar 31, 2022 | 27.25% |
| Dec 31, 2021 | 13.44% |